TGA Discussion Paper 3D Printing Technology in the Medical Device Field Australian Regulatory Considerations
|
|
- Sharlene Morris
- 6 years ago
- Views:
Transcription
1 TGA Discussion Paper 3D Printing Technology in the Medical Device Field Australian Regulatory Considerations MTAA Response - October 2017 October 2017 Australian Regulatory Considerations Page 1 of 7
2 Level 12, 54 Miller St, North Sydney NSW 2060 Australia P (+612) F (+612) Contents 1 Introduction International Context New definitions Responses to questions raised in the TGA Discussion Paper Statement of compliance with Essential Principles Regulatory status of 3D printers and anatomical models Regulatory status of 3D printed medical devices Regulatory status of entities engaged in 3D printing of medical devices Standards applicable to 3D printed medical devices Regulatory requirements to adequately protect consumers Other questions... 7 Copyright 2017 Medical Technology Association of Australia Limited (MTAA) To the extent permitted by law, all rights are reserved and no part of this publication covered by copyright may be reproduced or copied in any form or by any means except with the written permission of MTAA Limited. October 2017 Australian Regulatory Considerations Page 2 of 7
3 1 Introduction The Australian Medical Technology industry has successfully been utilising 3D printing for several decades, and recent technological advancements have improved the availability and the application of this technology. Currently 3D printers are generally considered to be manufacturing equipment that do not fall under the definition of a medical device and MTAA believes that 3D printers should not be regulated as a medical device unless they are intended by the Manufacturer or sponsor to be a medical device as defined by the Act. Custom made medical devices have been heavily influenced by this technology and we recommend regulatory reform to maintain Australia s high safety and efficacy standard of medical devices in the market as the use of this technology expands. 2 International Context On 17 th July 2017, the TGA circulated the discussion paper 3D Printing Technology in the Medical Device Field Australian Regulatory Considerations. The discussion paper was the subject of a subsequent workshop held on 10 th August 2017, where stakeholders from industry, healthcare professionals, consumer advocacy groups, science and academia exchanged views and expressed concerns. The recently adopted European Medical Device Regulation (MDR) 2017/745 of 5 April 2017 has introduced significant changes compared to the old Medical Devices Directive (MDD) 93/42/EEC and Active Implantable Medical Devices Directive (AIMDD) 90/385/EEC. Among the changes is a revised definition of custom-made devices 1 : custom-made device means any device specifically made in accordance with a written prescription of any person authorised by national law by virtue of that person's professional qualifications which gives, under that person's responsibility, specific design characteristics, and is intended for the sole use of a particular patient exclusively to meet their individual conditions and needs. However, mass-produced devices which need to be adapted to meet the specific requirements of any professional user and devices which are mass-produced by means of industrial manufacturing processes in accordance with the written prescriptions of any authorised person shall not be considered to be custom-made devices; Although the EU MDR does not specify what constitutes mass-produced, the US FDA sets the limit for custom-made devices at no more than 5 units per year of a particular device type. In addition, the FDA has introduced further restrictions to the use of custom-made devices, which can only be used for treating a sufficiently rare condition, such that conducting clinical investigations on such a device would be impractical October 2017 Australian Regulatory Considerations Page 3 of 7
4 The Australian regulations define a custom-made device a device that: a) is made specifically in accordance with a request by a health professional specifying the design characteristics or construction of the medical device; and b) is intended: i. to be used only in relation to a particular individual; or ii. to be used by the health professional to meet special needs arising in the course of his or her practice. The Australian definition for custom-made devices should be retained in its current form, because it specifically covers custom-made tools and instruments intended to be used by healthcare professionals. MTAA appreciates the opportunity to be involved in the consultation process for updating the regulatory framework to accommodate the use of 3D printing technology. MTAA identifies the need for dynamic legislation that supports the use of advancements in technology either in the medical device or the manufacturing process. MTAA supports similar legislative changes to custom made medical devices implemented in Europe and the USA to support the safe and effective use of 3D printing/ additive manufacturing. In the next sections, we provide more details in response to the TGA Discussion Paper. 3 New definitions The TGA Discussion Paper proposes the introduction of following definitions: customised medical devices a mass produced medical device that is supplied by a manufacturer with a specified intended purpose and that must be adapted or assembled, in accordance with the manufacturer s instructions, to suit an individual patient prior to use mass produced medical devices - medical devices that are produced in production runs or batches that consist of identical products. There may be different batches or runs of different sizes, but within a batch the items are identical. patient matched or patient specific devices based on a standard device template model that is matched to a patient s anatomy. Patient-matching can be accomplished by techniques such as scaling of the device using one or more anatomic references, or by using the full anatomic features from patient imaging. (from the FDA Additive Manufactured Devices Guidance 3 ) MTAA supports the introduction of these definitions with the highlighted change to assist in clarifying terminology used in relation to 3D printed medical devices. 3 October 2017 Australian Regulatory Considerations Page 4 of 7
5 4 Responses to questions raised in the TGA Discussion Paper 4.1 Statement of compliance with Essential Principles The TGA Discussion Paper asks whether Australian health consumers would benefit from adopting the European approach of providing a written statement in relation to compliance and justification of non-compliance of custom-made devices with the applicable Essential Principles (page 15 of the TGA Discussion Paper). We believe that, unless the reader is familiar with the Essential Principles, it is of little value to provide such a statement to lay persons. However, we support the requirement for the manufacturer to prepare and keep on file such a statement and provide it upon request to the TGA, the treating healthcare professional or the patient. 4.2 Regulatory status of 3D printers and anatomical models Currently 3D printers are generally considered to be manufacturing equipment that do not fall under the definition of medical devices, although they are used to make products that meet the definitions of a medical device (page 19 of the TGA Discussion Paper). We believe that 3D printers should not be regulated as medical devices unless they are intended by the Manufacturer or sponsor to be a medical device as defined by the Act. Anatomical models should be regulated as custom-made medical devices only if they are printed from imaging scans of a particular patient for the purpose to be used as a diagnosis or investigation of the anatomy of the patient. 4.3 Regulatory status of 3D printed medical devices In our opinion, a 3D printed medical devices should be regulated as one of the following: Custom-made devices if they fall under the existing definition of custom-made device and aligned with the latest definition of custom-made device in the EU MDR, i.e. they are not mass produced as per the new proposed definition; Custom-made devices should continue to be exempt from inclusion in the ARTG. It is understood though that ARTG inclusion will remain a condition for obtaining reimbursement using the standard health technology assessment (HTA) processes. Patient matched or patient specific devices if they are mass produced based on a standard device template model that is matched to a patient s anatomy, using one or more anatomic references, or by using the full anatomic features from patient imaging, i.e. as per the new proposed definition; Patient matched/ specific devices should be required to be included in the ARTG and should qualify for reimbursement, like any other medical devices. 3D printed implants that are patient matched/ specific devices should be considered to be of a kind that is not exempt, and be subjected to the rigorous premarket scrutiny applicable to implantable devices. Verification/ validation should be done on samples that October 2017 Australian Regulatory Considerations Page 5 of 7
6 bracketed the worst-case size configurations, to demonstrate compliance with applicable Essential Principles. We agree that the 3D printing process is more than assembly or adaptation for a particular patient by an entity other than the original manufacturer, which applies to customised devices. Hence 3D printed devices cannot be considered customised devices, as per the new proposed definition. 4.4 Regulatory status of entities engaged in 3D printing of medical devices Custom-made devices should continue to be exempt from entry in the ARTG and entities making custom-made devices should continue to be exempt from pre-market regulatory requirements applicable to manufacturers. However, entities such as hospital laboratories engaging in making patient matched/ specific devices on a commercial scale (i.e. mass produced) should be regulated as manufacturers. Manufacturer responsibilities include operating according to a quality management system as per ISO 13485; applying conformity assessment procedures suitable for the risk classification of the medical device; and post-market obligations such as reporting of malfunctions and adverse events. The regulatory treatment of 3D manufacturing should be the same as that of conventional subtractive manufacturing when it is used as an alternative to conventional subtractive manufacturing for standard off-the-shelf devices. 4.5 Standards applicable to 3D printed medical devices MTAA agrees that state-of-the-art standards that are applicable to medical devices in general should be applicable to 3D printed medical devices as well to demonstrate compliance with the Essential Principles of safety and performance. 4.6 Regulatory requirements to adequately protect consumers 3D printing technology has democratised medical device manufacturing due to its relative affordability. This has led to an increase in the number of entities engaging in manufacturing of medical devices, including of high-risk implantable devices. The number of high-risk 3D printed implants is on the rise and this represents an increase in risk to patient population. It is therefore important to distinguish between custom-made devices (that, by definition, are only made in very low numbers) and patient specific devices (that, by definition, are mass produced). The patient specific medical devices need to be regulated like any other medical devices, and entities engaging in 3D printing of such devices must be regulated as medical device manufacturers. October 2017 Australian Regulatory Considerations Page 6 of 7
7 4.7 Other questions Q1: Is the current custom-made regulatory pathway appropriate for patient specific 3D printed implantable medical devices and does this represent an appropriate level of risk mitigation for patient? A1: In our opinion, the current regulatory framework for custom-made devices does not represent an appropriate level of risk mitigation for patient specific 3D printed implantable medical devices manufactured on a commercial scale. Entities engaging in manufacturing patient specific 3D printed implantable medical devices should be regulated as manufacturers and such devices should be regulated as any other implantable medical devices. Q2: If the answer to Question 1 is no, then a fairly straightforward change could be to amend the definition of custom-made device in the Regulation. Is this a reasonable approach and is it enough? A2: The definition of custom-made devices should remain as is, but additional definitions for mass produced and patient specific medical devices should be included in the regulations, to differentiate the regulatory treatment of mass produced patient specific 3D printed devices from that of custom-made devices. Q3: What regulatory changes should be applied to ensure it is clear that the exclusion from being considered the manufacturer, i.e. in the case of customised does not apply to 3D printed devices? Should there be different arrangements for lower risk devices? A3: The definition of customised medical devices should be included in regulations to distinguish between entities, other than the original manufacturer, engaging in customising devices for a particular patient and entities engaging in the mass production of 3D printing patient specific devices. Different arrangement should apply to lower risk devices such as dental devices in Class I, IIa and IIb risk classification. Q4: What about 3D printed anatomical models what risk classification should be applied to them? A4: 3D printed anatomical models should be classified as Class IIa only when they are mass produced patient specific devices. October 2017 Australian Regulatory Considerations Page 7 of 7
Recast de la législation européenne et impact sur l organisation hospitalière
Recast de la législation européenne et impact sur l organisation hospitalière MEDICAL DEVICES IN BELGIUM. What s up? Brussels44Center 24.10.2017 Valérie Nys Need for changes? Regulatory system is highly
More informationMedical Devices cyber risks and threats
Medical Devices cyber risks and threats David Grainger Senior Medical Device Specialist MHRA The challenges of software medical device regulation. david.grainger@mhra.gov.uk Current framework 1998 In Vitro
More informationParenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)
Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) BACKGROUND (Reason or Purpose) The purpose of this Policy is to provide clear principles and guidance about
More informationPreparing for the new Regulations for healthcare providers
Preparing for the new Regulations for healthcare providers Cathal Brennan, Medical Device Assessor HPRA Information Day on Medical Devices 23 rd October 2014 Brussels, 26.9.2012 COM(2012) 542 final 2012/0266
More informationCOMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT. pursuant to Article 294(6) of the Treaty on the Functioning of the European Union
EUROPEAN COMMISSION Brussels, 9.3.2017 COM(2017) 129 final 2012/0266 (COD) COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT pursuant to Article 294(6) of the Treaty on the Functioning of the
More informationArticle 117 A Notified Body perspective, advice on how and when to engage notified bodies
TOPRA Annual Medical Devices Symposium 2017 Article 117 A Notified Body perspective, advice on how and when to engage notified bodies Theresa Jeary, Head of Notified Body Medical Devices, LRQA ENABLING
More informationHow to survive the MDR
How to survive the MDR Louis Habets LifetecZONe, 21 September 2017 1 Agenda About the Medical Device Regulation Specific project! Highlights only showing where to find Discussion and Questions LifetecZONe,
More informationJanuary 8, Licensing Requirements for Implantable Medical Devices Manufactured by 3D Printing; Draft Guidance. Dear Sir or Madame:
701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org January 8, 2019 Bureau of Policy, Science and International Programs Therapeutic Products
More informationSHTG primary submission process
Meeting date: 24 April 2014 Agenda item: 8 Paper number: SHTG 14-16 Title: Purpose: SHTG primary submission process FOR INFORMATION Background The purpose of this paper is to update SHTG members on developments
More informationBuilding Quality into Medical Device Documentation and Impact of New Device Regulation (Context: Inhaled Drug Devices) v4
Building Quality into Medical Device Documentation and Impact of New Device Regulation (Context: Inhaled Drug Devices) v4 Paul Brooks SVP Healthcare Solutions Representing BSI Notified Body EU Medical
More information25 th Workshop of the EURORDIS Round Table of Companies (ERTC)
25 th Workshop of the EURORDIS Round Table of Companies (ERTC) Healthcare Companies & European Reference Networks: Expectations & Potential for Collaboration Introduction Tuesday 26 September, 2017 (09:00
More informationTechnical Documentation - Key pit falls
Technical Documentation - Key pit falls Itoro Udofia, PhD Global Head, Orthopaedic & Dental Devices Presented by Ibim Tariah Ph.D Technical Director Healthcare Solutions September 2012 TFD00101ENUK Overview
More informationOffice for Nuclear Regulation
Office for Nuclear Regulation Redgrave Court Merton Road Bootle Merseyside L20 7HS www.hse.gov.uk/nuclear PROJECT ASSESSMENT REPORT Report Identifier: ONR-Policy-all-PAR-11-001 Revision: 2 Project: Implementation
More informationConformity assessment procedures for hip, knee and shoulder total joint replacements
1. INTRODUCTION NBRG 307/07 It is the primary purpose of this document to provide guidance to Manufacturers and Notified Bodies in dealing with the application of Directive 2005/50/EC on the reclassification
More information15 August Office of the Secretary PCAOB 1666 K Street, NW Washington, DC USA
15 August 2016 Office of the Secretary PCAOB 1666 K Street, NW Washington, DC 20006-2803 USA submitted via email to comments@pcaobus.org PCAOB Release No. 2016-003, PCAOB Rulemaking Docket Matter No. 034
More informationMapping Your Success 2013 BSI Healthcare Road Show
Mapping Your Success 2013 BSI Healthcare Road Show Welcome & Outline Objectives for Today Please let me introduce myself.. Gary Slack Global Director BSI Medical Devices Based London 2 Changing Global
More informationThis document is a preview generated by EVS
TECHNICAL REPORT ISO/TR 28380-2 First edition 2014-02-15 Health informatics IHE global standards adoption Part 2: Integration and content profiles Informatique de santé Adoption des normes globales IHE
More informationEN Official Journal of the European Union L 117/176 REGULATION (EU) 2017/746 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL.
Seite 1 von 176 5.5.2017 EN Official Journal of the European Union L 117/176 REGULATION (EU) 2017/746 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on in vitro diagnostic medical devices
More informationEN Official Journal of the European Union L 117/1 REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL.
Seite 1 von 200 5.5.2017 EN Official Journal of the European Union L 117/1 REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on medical devices, amending Directive
More information(R) Aerospace First Article Inspection Requirement FOREWORD
AEROSPACE STANDARD AS9102 Technically equivalent to AECMA pren 9102 Issued 2000-08 Revised 2004-01 REV. A Supersedes AS9012 (R) Aerospace First Article Inspection Requirement FOREWORD In December 1998,
More informationMinistry of Justice: Call for Evidence on EU Data Protection Proposals
Ministry of Justice: Call for Evidence on EU Data Protection Proposals Response by the Wellcome Trust KEY POINTS It is essential that Article 83 and associated derogations are maintained as the Regulation
More informationThe Medical Device Regulation: Transitioning between old and new
Association of British Healthcare Industries The Medical Device Regulation: Transitioning between old and new www.abhi.org.uk www.bdia.org.uk Introduction In May 2017, the new Medical Device Regulation
More informationThe EFPIA Perspective on the GDPR. Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference , Helsinki
The EFPIA Perspective on the GDPR Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference 26-27.9.2017, Helsinki 1 Key Benefits of Health Data Improved decision-making Patient self-management CPD
More informationGlobal Harmonization Task Force
Global Harmonization Task Force How to minimize risks without constraining innovation and harming free trade The role of international standards And their application at regional and national levels Cornelis
More informationReflection Paper on synergies between regulatory and HTA issues. DG SANTE Unit B4 Medical products: safety, quality, innovation
Reflection Paper on synergies between regulatory and HTA issues DG SANTE Unit B4 Medical products: safety, quality, innovation STAMP meeting, 28 June 2016 Outline Aim of the Reflection Paper Drafting process
More informationOfficial Journal of the European Union L 117. Legislation. Legislative acts. Volume May English edition. Contents REGULATIONS
Official Journal of the European Union L 117 English edition Legislation Volume 60 5 May 2017 Contents I Legislative acts REGULATIONS Regulation (EU) 2017/745 of the European Parliament and of the Council
More informationHealth Based Exposure Limits (HBEL) and Q&As
Health Based Exposure Limits (HBEL) and Q&As The EMA guideline (EMA/CHMP/ CVMP/ SWP/169430/2012) & EMA/CHMP/CVMP/SWP/463311/2016 Graeme McKilligan, UK, MHRA. Content Intent of HBEL Post Implementation
More informationConformity Assessment and Risk Management under Consideration of Applicable Harmonized Standards. Dipl.-Ing. Sven Wittorf, M.Sc. Lübeck,
Conformity Assessment and Risk Management under Consideration of Applicable Harmonized Standards Dipl.-Ing. Sven Wittorf, M.Sc. Lübeck, 2013-09-12 Declaration of Conformity Conformity Assessment Procedures
More informationNational Coordinated Registry Network (CRN) Think-tank
National Coordinated Registry Network (CRN) Think-tank The Value of Real World Data for Innovation within FDA What can CRNs offer? Murray Sheldon, MD Associate Director for Technology and Innovation FDA/CDRH
More informationEMA experience with the review of digital technology proposals in medicine development programmes
EMA experience with the review of digital technology proposals in medicine development programmes 3rd Industry Stakeholder Platform on R&D support, 18 May 2018 Francesca Cerreta, Scientific Advice An agency
More informationAS/NZS :2014
AS/NZS 4024.1100:2014 Australian/New Zealand Standard Safety of machinery Part 1100: Application guide AS/NZS 4024.1100:2014 AS/NZS 4024.1100:2014 This joint Australian/New Zealand standard was prepared
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 15223-1 Second edition 2012-07-01 Medical devices Symbols to be used with medical device labels, labelling and information to be supplied Part 1: General requirements Dispositifs
More informationEU MDR Deep Dive: Software/Digital Health Implications for Manufacturers/Developers. 19 JUNE 2018 ASQ RAPS MASSMEDIC Waltham Woods
EU MDR Deep Dive: Software/Digital Health Implications for Manufacturers/Developers 19 JUNE 2018 ASQ RAPS MASSMEDIC Waltham Woods Glen Emelock Sr. Partner, The CRO Group Lead Auditor, Technical Expert,
More informationJustice Select Committee: Inquiry on EU Data Protection Framework Proposals
Justice Select Committee: Inquiry on EU Data Protection Framework Proposals Response by the Wellcome Trust KEY POINTS The Government must make the protection of research one of their priorities in negotiations
More informationCENTER FOR DEVICES AND RADIOLOGICAL HEALTH. Notice to Industry Letters
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH Standard Operating Procedure for Notice to Industry Letters PURPOSE This document describes the Center for Devices and Radiological Health s (CDRH s, or Center
More information(Non-legislative acts) DECISIONS
4.12.2010 Official Journal of the European Union L 319/1 II (Non-legislative acts) DECISIONS COMMISSION DECISION of 9 November 2010 on modules for the procedures for assessment of conformity, suitability
More informationCAMD Transition Sub Group FAQ IVDR Transitional provisions
Disclaimer: CAMD Transition Sub Group FAQ IVDR Transitional provisions The information presented in this document is for the purpose of general information only and is not intended to represent legal advice
More informationSAUDI ARABIAN STANDARDS ORGANIZATION (SASO) TECHNICAL DIRECTIVE PART ONE: STANDARDIZATION AND RELATED ACTIVITIES GENERAL VOCABULARY
SAUDI ARABIAN STANDARDS ORGANIZATION (SASO) TECHNICAL DIRECTIVE PART ONE: STANDARDIZATION AND RELATED ACTIVITIES GENERAL VOCABULARY D8-19 7-2005 FOREWORD This Part of SASO s Technical Directives is Adopted
More informationINTERNATIONAL STANDARD
INTERNATIONAL STANDARD IEC 62220-1 First edition 2003-10 Medical electrical equipment Characteristics of digital X-ray imaging devices Part 1: Determination of the detective quantum efficiency Appareils
More informationCouncil of the European Union Brussels, 8 March 2017 (OR. en)
Council of the European Union Brussels, 8 March 2017 (OR. en) Interinstitutional File: 2012/0267 (COD) 10729/4/16 REV 4 LEGISLATIVE ACTS AND OTHER INSTRUMTS Subject: PHARM 44 SAN 285 MI 479 COMPET 403
More informationConvergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA
EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,
More informationMedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)
MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry
More informationWG food contact materials
WG food contact materials Monday 30 January European Commission DG SANTE, Unit E2 Food Processing Technologies and Novel Foods Food Contact Materials This presentation does not present any official views
More informationMachinery Directive 2006/42/EC
Machinery Directive 2006/42/EC All machinery and safety devices are subject to Directive 2006/42/EC, known as "Machinery Directive", implemented in Italy with Legislative Decree 17/2010. This Directive
More informationMedical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade
Medical Technology Association of NZ Proposed European Union/New Zealand Free Trade Agreement Submission to Ministry of Foreign Affairs & Trade February 2016 1 Introduction The Medical Technology Association
More informationETSI EN V1.5.1 ( ) Harmonized European Standard (Telecommunications series)
EN 300 330-2 V1.5.1 (2010-02) Harmonized European Standard (Telecommunications series) Electromagnetic compatibility and Radio spectrum Matters (ERM); Short Range Devices (SRD); Radio equipment in the
More informationPRIMATECH WHITE PAPER COMPARISON OF FIRST AND SECOND EDITIONS OF HAZOP APPLICATION GUIDE, IEC 61882: A PROCESS SAFETY PERSPECTIVE
PRIMATECH WHITE PAPER COMPARISON OF FIRST AND SECOND EDITIONS OF HAZOP APPLICATION GUIDE, IEC 61882: A PROCESS SAFETY PERSPECTIVE Summary Modifications made to IEC 61882 in the second edition have been
More informationTYPE APPROVAL PROCEDURE
Approval Amendment Record Approval Date Version Description 15/06/2012 1 Initial issue under MTM. Replaces Connex documents cml- 8.13-PR-002 & cml-8.21-po-168 30/11/2012 2 Document revised and updated
More informationThis document is a preview generated by EVS
INTERNATIONAL STANDARD ISO 16142-1 First edition 2016-03-01 Medical devices Recognized essential principles of safety and performance of medical devices Part 1: General essential principles and additional
More informationTECHNICAL AND OPERATIONAL NOTE ON CHANGE MANAGEMENT OF GAMBLING TECHNICAL SYSTEMS AND APPROVAL OF THE SUBSTANTIAL CHANGES TO CRITICAL COMPONENTS.
TECHNICAL AND OPERATIONAL NOTE ON CHANGE MANAGEMENT OF GAMBLING TECHNICAL SYSTEMS AND APPROVAL OF THE SUBSTANTIAL CHANGES TO CRITICAL COMPONENTS. 1. Document objective This note presents a help guide for
More informationAustralian Standard. Safety of machinery. Part 1801: Safety distances to prevent danger zones being reached by the upper limbs AS 4024.
AS 4024.1801 2006 AS 4024.1801 2006 Australian Standard Safety of machinery Part 1801: Safety distances to prevent danger zones being reached by the upper limbs This Australian Standard was prepared by
More informationTI Designs: Biometric Steering Wheel. Amy Ball TIDA-00292
www.ti.com 2 Biometric Steering Wheel - -Revised July 2014 www.ti.com TI Designs: Biometric Steering Wheel - -Revised July 2014 Biometric Steering Wheel 3 www.ti.com 4 Biometric Steering Wheel - -Revised
More informationTOOL #21. RESEARCH & INNOVATION
TOOL #21. RESEARCH & INNOVATION 1. INTRODUCTION This research and innovation Tool provides clear guidelines for analysing the interaction between new or revised EU legislation (including spending programmes)
More informationPiloting MDevSPICE - the Medical Device Software Process Assessment Framework
Piloting MDevSPICE - the Medical Device Software Process Assessment Framework Marion Lepmets Regulated Software Research Centre Dundalk Institute of Technology Dundalk, Ireland marion.lepmets@dkit.ie Fergal
More information4.1. Accurate: The information is a true reflection of the original observation.
SOP #: DOC-101 Page: 1 of 7 Effective Date: 1. POLICY STATEMENT: The Principal Investigator and research team members are required to prepare and maintain adequate and accurate case histories designed
More informationHaving regard to the Treaty on the Functioning of the European Union, and in particular Article 16 thereof,
Opinion of the European Data Protection Supervisor on the proposal for a Directive of the European Parliament and of the Council amending Directive 2006/126/EC of the European Parliament and of the Council
More informationCOUNCIL DIRECTIVE 93/42/EEC. of 14 June concerning medical devices
COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning medical devices THE COUNCIL OF THE EUROPEAN communities, Having regard to the Treaty establishing the European Economic Community, and in particular
More informationAustralian/New Zealand Standard
AS/NZS 1167.2:1999 Australian/New Zealand Standard Welding and brazing Filler metals Part 2: Filler metal for welding AS/NZS 1167.2:1999 This Joint Australian/New Zealand Standard was prepared by Joint
More informationGuidance for Industry and FDA Staff Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use
Guidance for Industry and FDA Staff Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use Document issued on: November 30, 2004 The draft of this document
More informationABHI Response to the Kennedy short study on Valuing Innovation
ABHI Response to the Kennedy short study on Valuing Innovation Introduction 1. The Association of British Healthcare Industries (ABHI) is the industry association for the UK medical technology sector.
More informationSMA Europe Code of Practice on Relationships with the Pharmaceutical Industry
Introduction SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry SMA Europe is an umbrella body of national Spinal Muscular Atrophy patient representative and research organisations
More informationAccreditation & Designation of NB
Accreditation & Designation of NB Bert Roossien Medical Devices Notified Body BSI Netherlands 07 June 2018 Copyright 2018 BSI. All rights reserved MDF1200 (EU) No 920/2013 In particular, they shall not
More informationFiscal 2007 Environmental Technology Verification Pilot Program Implementation Guidelines
Fifth Edition Fiscal 2007 Environmental Technology Verification Pilot Program Implementation Guidelines April 2007 Ministry of the Environment, Japan First Edition: June 2003 Second Edition: May 2004 Third
More informationCOUNCIL DIRECTIVE 93/42/EEC. of 14 June concerning medical devices
COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning medical devices THE COUNCIL OF THE EUROPEAN communities, Having regard to the Treaty establishing the European Economic Community, and in particular
More informationFinal Document. Title: The GHTF Regulatory Model. Authoring Group: Ad Hoc GHTF SC Regulatory Model Working Group
GHTF/AHWG-GRM/N1R13:2011 Final Document Title: The GHTF Regulatory Model Authoring Group: Ad Hoc GHTF SC Regulatory Model Working Group Endorsed by: The Global Harmonization Task Force Date: 13 April 2011
More informationMedical Education Activities
Medical Education Activities Author: Marie-Claire PICKAERT EFPIA Deputy Director General BioMed Alliance Brussels, 9 November 2016 MCP 07-11--2016 Declaration of Interest Marie-Claire Pickaert is a full-time
More informationEL PASO COMMUNITY COLLEGE PROCEDURE
For information, contact Institutional Effectiveness: (915) 831-6740 EL PASO COMMUNITY COLLEGE PROCEDURE 2.03.06.10 Intellectual Property APPROVED: March 10, 1988 REVISED: May 3, 2013 Year of last review:
More informationSustainable anaesthetic practise: joint stakeholder meeting Regulations v The Market 21 Portland Place 16 th November 2016
Sustainable anaesthetic practise: joint stakeholder meeting Regulations v The Market 21 Portland Place 16 th November 2016 Paul Sim Barema Council & Barema/AAGBI Environmental WG BSI Standards & Publishing
More informationJustin McCarthy John Amoore, Paul Blackett, Fran Hegarty, Richard Scott. Regulations, Guidance and Standards
Justin McCarthy John Amoore, Paul Blackett, Fran Hegarty, Richard Scott Regulations, Guidance and Standards 1 What s it all about? Clarity regarding the difference between: Regulations Guidance Standards
More informationAi Group Submission. in response to the REVIEW OF ELECTRICITY (CONSUMER SAFETY) ACT 2004 ISSUES PAPER
Ai Group Submission in response to the REVIEW OF ELECTRICITY (CONSUMER SAFETY) ACT 2004 ISSUES PAPER APRIL 2010 EXECUTIVE SUMMARY The Australian Industry Group (Ai Group) welcomes the opportunity to comment
More informationEU MDR: Review of Significant Changes and Timeline for Manufacturers. 12 December 2017 ASQ NEBG RAPS MASSMEDIC Waltham Woods
EU MDR: Review of Significant Changes and Timeline for Manufacturers 12 December 2017 ASQ NEBG RAPS MASSMEDIC Waltham Woods Glen Emelock Sr. Partner, The CRO Group Lead Auditor, Product Reviewer, NSAI
More informationDecember Eucomed HTA Position Paper UK support from ABHI
December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing
More informationQuestions and answers on the revised directive on restrictions of certain dangerous substances in electrical and electronic equipment (RoHS)
MEMO/08/763 Brussels, 3 December 2008 Questions and answers on the revised directive on restrictions of certain dangerous substances in electrical and electronic equipment (RoHS) What is RoHS about? The
More informationA FRAMEWORK FOR RISK CATEGORISATION AND CORRESPONDING CONTROLS FOR SaMD
A FRAMEWORK FOR RISK CATEGORISATION AND CORRESPONDING CONTROLS FOR SaMD This submission is Professionals Australia s response to the International Medical Device Regulators Forum Working Group s invitation
More informationIMPLEMENTING AGREEMENT NON-NUCLEAR ENERGY SCIENTIFIC AND TECHNOLOGICAL CO-OPERATION
IMPLEMENTING AGREEMENT between the Department of Energy of the United States of America and the European Commission for NON-NUCLEAR ENERGY SCIENTIFIC AND TECHNOLOGICAL CO-OPERATION In accordance with the
More informationAndalusian Agency for Health Technology Assessment (AETSA)
Andalusian Agency for Health Technology Assessment (AETSA) Seville, 22 nd of July, 2016 Comments on the concept paper Facilitating the translation of advanced therapies to patients in Europe 1 Introduction
More informationThis document is a preview generated by EVS
TECHNICAL SPECIFICATION ISO/TS 17503 First edition 2015-11-01 Statistical methods of uncertainty evaluation Guidance on evaluation of uncertainty using two-factor crossed designs Méthodes statistiques
More informationAustralian/New Zealand Standard
AS/NZS 61000.4.11:2005 AS/NZS 61000.4.11:2005 Australian/New Zealand Standard Electromagnetic compatibility (EMC) Part 4.11: Testing and measurement techniques Voltage dips, short interruptions and voltage
More informationAustralian Standard. Non-destructive testing Ultrasonic methods Evaluation and quality classification of metal bearing bonds (ISO :1992, MOD)
AS 2824 2003 AS 2824 Australian Standard Non-destructive testing Ultrasonic methods Evaluation and quality classification of metal bearing bonds (ISO 4386-1:1992, MOD) This Australian Standard was prepared
More informationIAASB Main Agenda (March, 2015) Auditing Disclosures Issues and Task Force Recommendations
IAASB Main Agenda (March, 2015) Agenda Item 2-A Auditing Disclosures Issues and Task Force Recommendations Draft Minutes from the January 2015 IAASB Teleconference 1 Disclosures Issues and Revised Proposed
More informationthe SPD company Dr Clive Simon, Principal, The SPD Company.
the SPD company With decades of local and international experience at the coalface, The SPD Company s specialists have built a solid repertoire of in-depth technical knowledge within the highly-regulated
More informationCouncil of the European Union Brussels, 15 June 2016 (OR. en)
Council of the European Union Brussels, 15 June 2016 (OR. en) Interinstitutional File: 2012/0266 (COD) 9364/3/16 REV 3 NOTE From: To: General Secretariat of the Council Permanent Representatives Committee
More informationAS This is a free 6 page sample. Access the full version online. Australian Standard GAUGING OF METRIC SCREW THREADS
AS 1014 1986 Australian Standard GAUGING OF METRIC SCREW THREADS This Australian standard was prepared by Committee ME/28, Screw Threads. It was approved on behalf of the Council of the Standards Association
More informationEUROPEAN CENTRAL BANK
C 273/2 Official Journal of the European Union 16.9.2011 III (Preparatory acts) EUROPEAN CENTRAL BANK EUROPEAN CENTRAL BANK OPINION OF THE EUROPEAN CENTRAL BANK of 23 August 2011 on a proposal for a Regulation
More informationIssues in Emerging Health Technologies Bulletin Process
Issues in Emerging Health Technologies Bulletin Process Updated: April 2015 Version 1.0 REVISION HISTORY Periodically, this document will be revised as part of ongoing process improvement activities. The
More informationAustralian/New Zealand Standard
Australian/New Zealand Standard Quality management and quality assurance Vocabulary This Joint Australian/New Zealand Standard was prepared by Joint Technical Committee QR/7, Quality Terminology. It was
More information2. Evidence themes and their importance along the development path
1. The issue On 12 th July 2017, MedCity, Digital Health.London and BSI hosted a Digital Health Technology and Evidence Stakeholder workshop. It brought together the key experts for the innovation development
More informationHerts Valleys Clinical Commissioning Group. Review of NHS Herts Valleys CCG Constitution
Herts Valleys Clinical Commissioning Group Review of NHS Herts Valleys CCG s constitution Agenda Item: 14 REPORT TO: HVCCG Board DATE of MEETING: 30 January 2014 SUBJECT: Review of NHS Herts Valleys CCG
More informationCOCIR SUSTAINABLE COMPETENCE IN ADVANCING HEALTHCARE
FEB 2018 IMPLEMENTING MEDICAL DEVICE REGULATION COCIR VIEWS ON THE WAY FORWARD COCIR SUSTAINABLE COMPETENCE IN ADVANCING HEALTHCARE European Coordination Committee of the Radiological, Electromedical and
More informationLife Sciences Regulatory
Life Sciences Regulatory Pharmaceuticals 2018 2 Life Sciences Regulatory Pharmaceuticals 2018 Top ranked in Chambers and Legal 500 for Life Sciences, pharmaceuticals and biotechnology. Allen & Overy LLP
More informationIntegrated Scientific Advice Workshop: ISPOR Glasgow
Integrated Scientific Advice Workshop: ISPOR Glasgow Early Integrated Scientific Advice in Product Development: Get Real and Adapt to Accelerate Patient Access ICONplc.com Overview At today s patient-centered
More informationEDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS
EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE 1992-2012: 20 YEARS OF EXPERIENCE 22-23 March 2012 EDQM, Strasbourg, France ABSTRACTS PLENARY SESSION, 22 March 2012 ABSTRACT 1.3 The Evolution
More informationAspects Of Quality Assurance In Medical Devices Production
Aspects Of Quality Assurance In Medical Devices Production LUCIANA CRISTEA MIHAELA BARITZ DIANA COTOROS ANGELA REPANOVICI Precision Mechanics and Mechatronics Department Transilvania University of Brasov
More informationFebruary 5, 2010 VIA ELECTRONIC SUBMISSION
February 5, 2010 VIA ELECTRONIC SUBMISSION Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Re: Current Good Manufacturing Practice
More informationclarification to bring legal certainty to these issues have been voiced in various position papers and statements.
ESR Statement on the European Commission s proposal for a Regulation on the protection of individuals with regard to the processing of personal data on the free movement of such data (General Data Protection
More informationOphthalmic optics Spectacle frames Requirements and test methods
(ISO 12870:2012 IDT) Australian/New Zealand Standard Ophthalmic optics Spectacle frames Requirements and test methods AS/NZS ISO 12870:2012 This Joint Australian/New Zealand Standard was prepared by Joint
More informationPosition Paper.
Position Paper Brussels, 30 September 2010 ORGALIME OPINION ON THE POSITION OF THE COUNCIL AT FIRST READING WITH A VIEW TO THE ADOPTION OF A REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL LAYING
More informationImportance of ICH Guidance in Fulfilling Process Validation Requirements
Importance of ICH Guidance in Fulfilling Process Validation Requirements Presented by: Gamal Amer All rights reserved. Do not copy without permission. Principal 1 Premier Compliance Services, Inc. Process
More informationRADIO SPECTRUM POLICY GROUP. Commission activities related to radio spectrum policy
EUROPEAN COMMISSION Directorate-General for Communications Networks, Content and Technology Electronic Communications Networks and Services Radio Spectrum Policy Group RSPG Secretariat Brussels, 03 October
More information